Proteases and cancer invasion: from belief to certainty. AACR meeting on proteases and protease inhibitors in cancer, Nyborg, Denmark, 14-18 June 1998.
Blasi
F
F
DIBIT, H. San Raffaele, Milan, Italy. blasi.francesco@hsr.it
Stoppelli
M P
MP
D000818:Animals; D017209:Apoptosis; D002403:Cathepsins / Q000502:physiology; D002455:Cell Division; D017364:Collagenases / Q000235:genetics; D004622:Embryo, Mammalian; D010450:Endopeptidases / Q000502:physiology*; D006801:Humans; D020783:Matrix Metalloproteinase 7; D020780:Matrix Metalloproteinase 9; D008666:Metalloendopeptidases / Q000235:genetics / Q000502:physiology; D051379:Mice; D008822:Mice, Transgenic; D009361:Neoplasm Invasiveness / Q000503:physiopathology*; D010960:Plasminogen Activators / Q000502:physiology; D015849:Plasminogen Inactivators / Q000502:physiology; D011480:Protease Inhibitors / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000037:antagonists & inhibitors; D055293:Receptors, Urokinase Plasminogen Activator; D014568:Urokinase-Type Plasminogen Activator / Q000037:antagonists & inhibitors; D014652:Vascular Diseases / Q000503:physiopathology